Organon faces profitability challenges and revenue declines. The valuation appears fair given the weak revenue outlook. See ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the ...

The Food and Drug Administration approved the drug for adult patients with bullous pemphigoid, which mainly affects the ...

When Organon, a global pharmaceutical company focused on women's health, sought a heating and cooling solution to meet their 2035 net zero goals, they found the answer with Trane. NORTHAMPTON, MA / AC ...

Will support spray drying and unit operations including granulation, encapsulation, compression and coating for oral dosage ...

CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing USYMRO® to the referen ...

Organon (OGN) ended the recent trading session at $10.19, demonstrating a +1.49% change from the preceding day's closing price. The stock's change was more than the S&P 500's daily gain of 0.94%.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Weybridge, UK: Today, Veriton Pharma Ltd is announced as the new company name for Special Products Ltd. This name change has occurred both to incorporate the company’s past heritage with its ...